بوابة الشروق
بوابة الشروق
Ready to play
Ready to play
The use of digital Tomosynthesis technology in breast cancer diagnosis increases detection accuracy, especially for small tumors and in cases of dense tissue. It outperforms traditional mammography, which may struggle to identify cancer cells early on or among dense tissues. This technology was approved by the Food and Drug Administration in 2011 and allows for three-dimensional imaging of the breast. This helps doctors pinpoint tumor locations more accurately and determine treatment paths more effectively, particularly since the technology is more precise in detecting early changes that may require swift intervention. However, the higher cost of Tomosynthesis may limit its widespread use. Nonetheless, its benefits in early diagnosis and accuracy strengthen its role in improving breast cancer treatment outcomes.
Notice: This Is an AI-Generated Summary
Comments (0)